Nicergoline (1, 6-dimethyl-8 beta-(5-bromonicotinoyl-oxymethyl) -10 alpha-methoxy-ergoline) is an alpha-adrenergic receptor blocking agent (Arcari et al., 1968) which affects cerebral blood flow by reducing cerebrovascular resistance (Benzi et al., 1971 ). The present study was undertaken to assess the acute effect of the drug on cerebral blood flow and blood pressure in patients with cerebrovascular disease.
Methods
Thirteen patients (10 with multi-infarct dementia of moderate degree and three with transient ischaemic attacks) gave informed consent to measurement of cerebral blood flow before and after intravenous injection of 2 mg nicergoline, using the intracarotid 133Xenon technique developed by Wilkinson et al. (1969) . The studies were performed under general anaesthesia before cerebral angiography carried out for diagnostic purposes. Anaesthesia was induced by methohexitone and acoline, and maintained by nitrous oxide and oxygen supplemented by phenoperidine. Cerebral blood flow was estimated from the slope of the first two minutes of the semilogarithmic display of the clearance curve described by Olesen et al. (1971) . PaCO2 and blood pressure were monitored throughout. A first estimation of cerebral blood flow was made not less than 30 minutes after induction of anaesthesia. A second estimation was made 30 minutes after the first at varying times after intravenous injection of nicergoline.
Results
Cerebral blood flow was measured at times ranging from two to 20 min after intravenous injection of 2 mg nicergoline; the results are given in the Table. In no case did the PaCO2 vary by more than 2.0 mmHg between the pre-and postinjection measurements of cerebral blood flow.
Blood pressure fell by not more than 10 mmHg in all but one case in which it rose by 10 mmHg. The cerebral blood flow showed an increase in seven cases, a decrease in four, and was unchanged in two.
Discussion
The finding in seven out of 13 cases of an increase in cerebral blood flow, without significant change Previous work in our laboratory indicates that the effect of nicergoline may have been greater than is demonstrated in these results (Palmer et al., 1977) . In sequential measurements of cerebral blood flow at an interval of about 30 minutes under the general anaesthetic regime used in the present study, there was a fall in flow at the second measurement ranging from 0 to 46% (mean 24%) 
